FR2225171A1 - - Google Patents

Info

Publication number
FR2225171A1
FR2225171A1 FR7412336A FR7412336A FR2225171A1 FR 2225171 A1 FR2225171 A1 FR 2225171A1 FR 7412336 A FR7412336 A FR 7412336A FR 7412336 A FR7412336 A FR 7412336A FR 2225171 A1 FR2225171 A1 FR 2225171A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7412336A
Other versions
FR2225171B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COMMUNITY BLOOD COUNCIL GREATE
Original Assignee
COMMUNITY BLOOD COUNCIL GREATE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COMMUNITY BLOOD COUNCIL GREATE filed Critical COMMUNITY BLOOD COUNCIL GREATE
Publication of FR2225171A1 publication Critical patent/FR2225171A1/fr
Application granted granted Critical
Publication of FR2225171B1 publication Critical patent/FR2225171B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FR7412336A 1973-04-11 1974-04-08 Expired FR2225171B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35022573A 1973-04-11 1973-04-11
US442276A US3925344A (en) 1973-04-11 1974-02-13 Plasma protein substitute

Publications (2)

Publication Number Publication Date
FR2225171A1 true FR2225171A1 (fr) 1974-11-08
FR2225171B1 FR2225171B1 (fr) 1977-08-12

Family

ID=26996533

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7412336A Expired FR2225171B1 (fr) 1973-04-11 1974-04-08

Country Status (9)

Country Link
US (1) US3925344A (fr)
BR (1) BR7402876D0 (fr)
CA (1) CA1033721A (fr)
DE (1) DE2417619C2 (fr)
FR (1) FR2225171B1 (fr)
GB (1) GB1427903A (fr)
NL (1) NL7404140A (fr)
SE (1) SE429195B (fr)
SU (1) SU629854A3 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0290252A2 (fr) * 1987-05-05 1988-11-09 Majesty The Queen In Right Of Canada As Represented By The Minister Of National Defence Of Her Majesty's Canadian Gov. Her Substitut du sang pasteurisable, lyophilisable, à base d'hémoglobine
EP0302734A2 (fr) * 1987-08-06 1989-02-08 Oxygenetics Inc. Procédé en continu pour la modification de substances biologiques actives et produits obtenus
EP0685492A2 (fr) * 1994-05-31 1995-12-06 Wolfgang Prof. Dr.Dr. Barnikol Procédé de préparation d'hyperpolymères d'hémoglobine de poids moléculaire uniforme

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449885C3 (de) * 1974-10-21 1980-04-30 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung von chemisch modifizierten haltbaren Hämoglobinpräparaten sowie das nach diesem Verfahren hergestellte modifizierte Hämoglobinpräparat
US4001200A (en) * 1975-02-27 1977-01-04 Alza Corporation Novel polymerized, cross-linked, stromal-free hemoglobin
US4009267A (en) * 1975-09-09 1977-02-22 Diagnostic Data, Inc. Cross-linked orgotein
CA1055932A (fr) * 1975-10-22 1979-06-05 Hematech Inc. Succedane du sang comparable a l'hemoglobine
US4343715A (en) * 1980-10-10 1982-08-10 Duke University Immobilized hemoglobin, and processes for extracting oxygen from fluids using the same
US4427416A (en) 1980-10-10 1984-01-24 Duke University Processes for extracting oxygen from fluids using immobilized hemoglobin
US4473496A (en) * 1981-09-14 1984-09-25 The United States Of America As Represented By The Secretary Of The Army Intramolecularly crosslinked hemoglobin
DE3320752A1 (de) * 1983-06-09 1984-12-13 Wolfgang Prof. Dr.Dr. 6500 Mainz Barnikol Lumineszierende schichten zur verwendung in vorrichtungen zur bestimmung der sauerstoffkonzentration in gasen und dergleichen durch messung der lumineszensverringerung
DE3340592A1 (de) * 1983-11-10 1985-05-23 B. Braun Melsungen Ag, 3508 Melsungen Konjugate makromolekularer verbindungen an haemoglobine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
USRE34271E (en) * 1984-06-27 1993-06-01 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4598064A (en) * 1984-06-27 1986-07-01 University Of Iowa Research Foundation Alpha-alpha cross-linked hemoglobins
US4600531A (en) * 1984-06-27 1986-07-15 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4584130A (en) * 1985-03-29 1986-04-22 University Of Maryland Intramolecularly cross-linked hemoglobin and method of preparation
US5753616A (en) * 1986-11-10 1998-05-19 Biopure Corporation Method for producing a stable polymerized hemoglobin blood-substitute
US5955581A (en) * 1986-11-10 1999-09-21 Biopure Corporation Method for producing a stable polymerized hemoglobin blood-substitute
US5189146A (en) * 1987-05-05 1993-02-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Pasteurizable, freeze-driable hemoglobin-based blood substitute
US5248766A (en) * 1990-08-17 1993-09-28 Baxter International Inc. Oxirane-modified hemoglobin based composition
HUT64571A (en) * 1990-11-29 1994-01-28 Upjohn Co A method for producing hemoglobin preparatives containing imido ester cross bind
US5900477A (en) * 1992-01-30 1999-05-04 Baxter International, Inc. Use of hemoglobin in the treatment of hemorrhagic shock
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
US5980954A (en) 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
US6669965B2 (en) 1992-02-07 2003-12-30 Vasogen Ireland Limited Method of treating atherosclerosis
GB9617611D0 (en) * 1996-08-22 1996-10-02 Vasogen Inc Treatment of autoimmune disease
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
JPH10501823A (ja) * 1995-04-10 1998-02-17 バクスター、インターナショナル、インコーポレイテッド クモ膜下出血の治療における架橋ヘモグロビンの使用
EP0854151A1 (fr) 1997-01-20 1998-07-22 SanguiBioTech AG Procédé pour obtenir des fractions uniformes d'hyperpolymères d'hémoglobine
US5814601A (en) * 1997-02-28 1998-09-29 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
DE69831248T2 (de) * 1997-02-28 2006-04-13 The Regents Of The University Of California, Oakland Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen
CA2233725A1 (fr) 1998-03-31 1999-09-30 Hemosol Inc. Complexes d'amidon hydroxyethyles d'hemoglobine
US7271145B2 (en) * 2002-01-11 2007-09-18 Sangart, Inc. Methods and compositions for oxygen transport comprising modified hemoglobin in plasma
WO2003059287A2 (fr) * 2002-01-11 2003-07-24 Sangart, Inc. Procedes et compositions de transport d'oxygene comprenant un transporteur d'oxygene et un cristalloide en solution hypertonique
SI1465643T1 (sl) 2002-01-11 2008-06-30 Sangart Inc Postopki in sestavki za transport kisika z visokoafiniteto za kisik
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US20050164915A1 (en) * 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
JP3912206B2 (ja) * 2002-07-05 2007-05-09 株式会社日立製作所 筒内直接燃料噴射装置用燃料ポンプ
US7135554B1 (en) 2004-01-27 2006-11-14 Biopure Corporation Method of forming a polymerized hemoglobin solution from stabilized hemoglobin
JP2008511674A (ja) * 2004-08-31 2008-04-17 サンガート， インコーポレイテッド 酸素運搬成分を使用して血流力学的安定性を増強する方法
US8273857B2 (en) * 2009-09-22 2012-09-25 Jen-Chang Hsia Compositions and methods of use of neurovascular protective multifunctional polynitroxylated pegylated carboxy hemoglobins for transfusion and critical care medicine
US8084581B1 (en) * 2011-04-29 2011-12-27 Bing Lou Wong Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
WO2014179793A1 (fr) 2013-05-03 2014-11-06 Washington University Composition de succédané de sang et procédé d'utilisation
RU2749266C1 (ru) * 2020-02-10 2021-06-07 Богдан Иванович Асатуров Способ получения биоплазмозаменителя гемодинамического действия

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE945650C (de) * 1952-01-24 1956-07-12 Charles B Knox Gelatine Co Inc Verfahren zur Herstellung von als Blutplasmastreckmittel dienenden serologisch vertraeglichen Proteinderivaten
SE343210B (fr) * 1967-12-20 1972-03-06 Pharmacia Ab

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0290252A2 (fr) * 1987-05-05 1988-11-09 Majesty The Queen In Right Of Canada As Represented By The Minister Of National Defence Of Her Majesty's Canadian Gov. Her Substitut du sang pasteurisable, lyophilisable, à base d'hémoglobine
EP0290252A3 (en) * 1987-05-05 1989-01-18 Jen-Chang Hsia Pasteurizable, freeze-driable hemoglobin-based blood substitute
EP0302734A2 (fr) * 1987-08-06 1989-02-08 Oxygenetics Inc. Procédé en continu pour la modification de substances biologiques actives et produits obtenus
EP0302734A3 (en) * 1987-08-06 1990-01-31 Oxygenetics Inc. Continuous processes for modifying biologically active materials and the products therefrom
EP0685492A2 (fr) * 1994-05-31 1995-12-06 Wolfgang Prof. Dr.Dr. Barnikol Procédé de préparation d'hyperpolymères d'hémoglobine de poids moléculaire uniforme
EP0685492A3 (fr) * 1994-05-31 1996-07-10 Barnikol Wolfgang Procédé de préparation d'hyperpolymères d'hémoglobine de poids moléculaire uniforme.
EP1097943A1 (fr) * 1994-05-31 2001-05-09 SanguiBioTech AG Procédé de préparation d'hyperpolymères d'hémoglobine de poids moléculaire uniforme

Also Published As

Publication number Publication date
CA1033721A (fr) 1978-06-27
SU629854A3 (ru) 1978-10-25
GB1427903A (en) 1976-03-10
BR7402876D0 (pt) 1974-12-03
FR2225171B1 (fr) 1977-08-12
DE2417619C2 (de) 1986-10-23
NL7404140A (fr) 1974-10-15
SE429195B (sv) 1983-08-22
US3925344A (en) 1975-12-09
DE2417619A1 (de) 1974-10-31

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU465372B2 (fr)
FR2225171B1 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474511B2 (fr)
AU465453B2 (fr)
AU471343B2 (fr)
AU465434B2 (fr)
AU450229B2 (fr)
AR201229Q (fr)
AU466283B2 (fr)
AU472848B2 (fr)
AR199451A1 (fr)
AR196382A1 (fr)
AR193950A1 (fr)
AR200256A1 (fr)
AU447540B2 (fr)
AR200885A1 (fr)
AU461342B2 (fr)
AR197627A1 (fr)
AR195948A1 (fr)
AR201432A1 (fr)
AU471461B2 (fr)
AR210729A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse